Results 131 to 140 of about 1,999,370 (297)

Comparing the paths of Hedgehog release in artificial and natural settings

open access: yesFEBS Letters, EarlyView.
Hh morphogens require solubilization factors to overcome their tight association with the plasma membrane and signal to distant cells, but the precise functions of these factors are controversial. Here, we use published in vivo observations as the most relevant evidence to test their suggested functions and discuss contradictions and gaps between in ...
Janna Puschmann, Kay Grobe
wiley   +1 more source

[Texas Instruments Press Releases, September-October 1962]

open access: yes, 1962
1. Release dated September 11, 1962 is in regard to the use of TI's digital telemetry encoder in NASA's Mariner 2 spacecraft. 2. Release dated September 19, 1962 announces the appointment of H. W.
Texas Instruments Incorporated
core  

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

[Texas Instruments Press Releases, January-February 1967]

open access: yes, 1967
1. Release dated January 1, 1967 announces the development of the TI-KOTE ''C'', a blend of metallic carbides used as a coating for various surfaces. 2. Release dated January 3, 1967 announces the award of a three-year $21 million contract for classified
Texas Instruments Incorporated
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

[Texas Instruments Press Releases, January-March 1960]

open access: yes, 1960
1. Release dated January 14, 1960 is in regard to a Boeing contract awarded to TI for 37 telemetry systems for the Bomarc C-2 missile. 2. Release dated January 14, 1960 is in regard to two Convair Astronautics contracts awarded to TI for 24 telemetry ...
Texas Instruments Incorporated
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

[Texas Instruments Press Releases, May-June 1970]

open access: yes, 1970
1. Press release dated May 4, 1970 announces the availability of a new application report on the SN75450 interface integrated circuit, CA-150. 2. Press release dated May 5, 1970 announces the development of a new process control computer, designed ...
Texas Instruments Incorporated
core  

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy